BOTOX VISTA® (onabotulinumtoxinA) for Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Latest Information Update: 22 Oct 2024
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hypertrophy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors AbbVie
Most Recent Events
- 18 Oct 2024 Planned primary completion date changed from 10 Jan 2026 to 23 Dec 2025.
- 18 Oct 2024 Status changed from recruiting to active, no longer recruiting.
- 18 Dec 2023 Planned primary completion date changed from 17 Jan 2026 to 10 Jan 2026.